Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

PURPOSE: To evaluate the efficacy of cytokine-induced killer (CIK) cell therapy in the treatment of hepatocellular carcinoma. MATERIALS AND METHODS: Randomized phase II and III trials on CIK cell-based therapy were identified by electronic searches using a combination of "hepatocellular carcino...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ma, Yue, Xu, Ying-Chun, Tang, Lei, Zhang, Zan, Wang, Jian, Wang, Hong-Xia
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Methodology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3514101/
https://ncbi.nlm.nih.gov/pubmed/23210562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2162-3619-1-11
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars